CYB5R3 and methemoglobinemia: In contrast, type II RCM, characterized by the complete or almost complete loss of activity of the CYB5R3 enzymes leads to devastating developmental and neurological disease in humans, likely due to fatty acid disturbances besides methemoglobinemia [10,11].